Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4961 USD | +104.99% | -19.98% | -75.80% |
Apr. 15 | Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index | CI |
Mar. 27 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.71M |
---|---|---|---|---|---|
Net income 2022 | -16M | Net income 2023 | -8M | EV / Sales 2022 | - |
Net cash position 2022 | 11.88M | Net cash position 2023 | 3.67M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.15
x | P/E ratio 2023 |
-0.19
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.44% |
1 day | +104.99% | ||
1 week | -19.98% | ||
Current month | -46.08% | ||
1 month | -69.19% | ||
3 months | -70.64% | ||
6 months | -83.24% | ||
Current year | -75.80% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Martino
CEO | Chief Executive Officer | 68 | 21-10-12 |
Howard Levy
CTO | Chief Tech/Sci/R&D Officer | 70 | 21-10-12 |
Laura Goldberg
LAW | General Counsel | - | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Stevens
BRD | Director/Board Member | 75 | 11-05-31 |
J. Buchi
CHM | Chairman | 69 | 21-10-12 |
Michael Martino
CEO | Chief Executive Officer | 68 | 21-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.4961 | +104.99% | 7,872 |
24-04-18 | 0.242 | -3.20% | 15,034 |
24-04-17 | 0.25 | -16.67% | 46,877 |
24-04-16 | 0.3 | 0.00% | 32,446 |
24-04-15 | 0.3 | -51.61% | 62,569 |
Delayed Quote OTC Markets, April 19, 2024 at 03:47 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-75.80% | 563K | |
-3.10% | 102B | |
+2.11% | 96.37B | |
-1.80% | 21.37B | |
-17.75% | 20.92B | |
-6.91% | 18.64B | |
-42.00% | 16.4B | |
-28.19% | 13.53B | |
+0.18% | 13.28B | |
+19.90% | 10.85B |
- Stock Market
- Equities
- AMPE Stock